Top Factor Driving Enzyme-Linked Immunosorbent Assay Testing Market Growth in 2025: Rising Incidence Of Infectious Disorders Driving Growth In ELISA Testing Market

How Big Is the Enzyme-Linked Immunosorbent Assay Testing Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been significant growth in the size of the enzyme-linked immunosorbent assay (ELISA) testing market. It is predicted to increase from $2.85 billion in 2024 to $3.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The escalation seen in the historical period can be linked to the widespread nature of chronic diseases, the extra funding and focus on biomedical research, approval of ELISA tests from regulatory authorities, government-driven initiatives, and programs designed to raise health awareness.

The market size for enzyme-linked immunosorbent assay testing is predicted to experience robust growth in the coming years, reaching $3.88 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. This anticipated growth for the forecasted period can be ascribed to factors such as an increased interest in personalized medicine, an expanding elderly population, an enhanced focus on early detection, better healthcare accessibility, as well as a burgeoning requirement for chronic illness monitoring. The major trends anticipated for this period involve technological evolution, an increasing demand for point-of-care testing, a broader scope of application areas, the incorporation of high-throughput screening, and the advent of digital ELISA.

What Are the Primary Growth Drivers for the Enzyme-Linked Immunosorbent Assay Testing Market?
The enzyme-linked immunosorbent assay testing market is slated for growth, driven by escalating cases of infectious disorders. These diseases, triggered by pathogenic elements like bacteria, viruses, fungi, or parasites, are highly contagious and affect different body systems. The rise in infectious diseases is linked to increased worldwide travel and growing antimicrobial resistance, which makes controlling infections challenging. Enzyme-linked immunosorbent assay (ELISA) testing provides a possible solution by reliably identifying and measuring specific antigens or antibodies associated with these infections, thereby enhancing diagnostic accuracy, monitoring disease progression, and assessing treatment efficacy. For example, in February 2024, the World Health Organization-a Switzerland-based intergovernmental public health body-published data showing a total of 58,114 measles cases in 2023 in the European Region, a substantial increase from 941 cases in 2022. This surge in infectious diseases underscores the need for ELISA testing, thereby fueling growth in its market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19417&type=smp

Who Are the Dominant Companies Influencing Enzyme-Linked Immunosorbent Assay Testing Market Trends?
Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc., Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

How Is the Enzyme-Linked Immunosorbent Assay Testing Market Evolving?
Leading firms in the enzyme-linked immunosorbent assay testing market are expanding their product range through innovative solutions, such as innovative enzyme-linked immunosorbent assay (ELISA) kits. These are modern iterations of ELISA tests, enhancing diagnostic precision and accommodating assorted research and clinical needs. The innovative Enzyme-Linked Immunosorbent Assay (ELISA) kits are designed to offer better levels of precision, sensitivity, and ease of use for detecting and quantifying biomarkers. For example, Charles River Laboratories, an American pharmaceutical company, launched a new ELISA kit in February 2023 for detecting and quantifying any residual host cell proteins (HCP) present in CHO-based biotherapeutics. The revolutionary kit uses avian immunoglobulin Y (IgY) antibodies originating from specific pathogen-free (SPF) chicken eggs, offering improved sensitivity and specificity with the ability to detect levels as low as 0.1 ng/mL and ensuring 90% antibody coverage. The introduction of this kit aims to enhance biopharmaceutical development's quality control, guarantee the safety and effectiveness of new therapies and provide flexibility for clients to use it either independently or with assistance from Charles River's experts.

What Are the Different Segmentations in the Enzyme-Linked Immunosorbent Assay Testing Market?
The enzyme-linked immunosorbent assay testingmarket covered in this report is segmented -

1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users

Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/enzyme-linked-immunosorbent-assay-testing-global-market-report

Which Region Is at the Forefront of the Enzyme-Linked Immunosorbent Assay Testing Market?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2024. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Enzyme-Linked Immunosorbent Assay Testing Global Market Report?

- Market Size Analysis: Analyze the Enzyme-Linked Immunosorbent Assay Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Enzyme-Linked Immunosorbent Assay Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Enzyme-Linked Immunosorbent Assay Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Enzyme-Linked Immunosorbent Assay Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19417

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.